A Metabolomic Analysis of Two Intravenous Lipid Emulsions in a Murine Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kalish, Brian T ^a   Le, Hau D ^a,b   Gura, Kathleen M ^a   Bistrian, Bruce R ^b   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; INTRALIPID; OMEGAVEN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FATTY LIVER; IN VIVO STUDY; INTRAVENOUS ADMINISTRATION; LIPID PEROXIDATION; LIPOGENESIS; MALE; METABOLOMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; THERAPY EFFECT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; FATTY LIVER; LIPID PEROXIDATION; MALE; MEMBRANE LIPIDS; METABOLOME; METABOLOMICS; MICE; OXIDATIVE STRESS; PARENTERAL NUTRITION SOLUTIONS; PHOSPHOLIPIDS; TRIGLYCERIDES;

ANIMALIA; MURINAE; MUS;

EID: 84875681550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059653     Document Type: Article

References (33)

1. Kelly DA, (1998) Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 14: 153-157.
2. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, et al. (2012) Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr 161: 723-728.e2 doi:10.1016/j.jpeds.2012.03.062.
3. Meisel JA, Le HD, De Meijer VE, Nose V, Gura KM, et al. (2011) Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 46: 666-673 doi:10.1016/j.jpedsurg.2010.08.018.
4. Alwayn IPJ, Gura K, Nose V, Zausche B, Javid P, et al. (2005) Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 57: 445-452 doi:10.1203/01.PDR.0000153672.43030.75.
5. Puder M, Valim C, Meisel JA, Le HD, De Meijer VE, et al. (2009) Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 250: 395-402 doi:10.1097/SLA.0b013e3181b36657.
6. Javid PJ, Greene AK, Garza J, Gura K, Alwayn IPJ, et al. (2005) The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg 40: 1446-1453 doi:10.1016/j.jpedsurg.2005.05.045.
7. Burdge GC, Calder PC, (2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45: 581-597 doi:10.1051/rnd:2005047.
8. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N, (2001) Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42: 1257-1265.
9. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, et al. (2005) Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46: 269-280 doi:10.1194/jlr.M400225-JLR200.
10. Nassar BA, Huang YS, Manku MS, Das UN, Morse N, et al. (1986) The influence of dietary manipulation with n-3 and n-6 fatty acids on liver and plasma phospholipid fatty acids in rats. Lipids 21: 652-656.
11. Simopoulos AP, (1991) Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54: 438-463.
12. Spite M, Serhan CN, (2010) Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107: 1170-1184 doi:10.1161/CIRCRESAHA.110.223883.
13. Serhan CN, (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101-137 doi:10.1146/annurev.immunol.25.022106.141647.
14. Stoll B, Horst DA, Cui L, Chang X, Ellis KJ, et al. (2010) Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs. J Nutr 140: 2193-2200 doi:10.3945/jn.110.125799.
15. Kasmi El KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, et al. (2012) Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology 55: 1518-1528 doi:10.1002/hep.25500.
16. Kosters A, Karpen SJ, (2010) The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 30: 186-194 doi:10.1055/s-0030-1253227.
17. Clayton PT, Whitfield P, Iyer K, (1998) The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14: 158-164.
18. Hao W, Wong OY, Liu X, Lee P, Chen Y, et al. (2010) ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg 45: 2412-2418 doi:10.1016/j.jpedsurg.2010.08.044.
19. Day CP, James OF, (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
20. Lespine A, Fernandez Y, Periquet B, Galinier A, Garcia J, et al. (2001) Total parenteral nutrition decreases liver oxidative metabolism and antioxidant defenses in healthy rats: comparative effect of dietary olive and soybean oil. JPEN J Parenter Enteral Nutr 25: 52-59.
21. Hasanoǧlu A, Dalgiç N, Tümer L, Atalay Y, Cinasal G, et al. (2005) Free oxygen radical-induced lipid peroxidation and antioxidant in infants receiving total parenteral nutrition. Prostaglandins Leukot Essent Fatty Acids 73: 99-102 doi:10.1016/j.plefa.2005.04.015.
22. Hong L, Wang X, Wu J, Cai W, (2009) Mitochondria-initiated apoptosis triggered by oxidative injury play a role in total parenteral nutrition-associated liver dysfunction in infant rabbit model. J Pediatr Surg 44: 1712-1718 doi:10.1016/j.jpedsurg.2009.04.002.
23. Hong L, Wu J, Cai W, (2007) Glutathione decreased parenteral nutrition-induced hepatocyte injury in infant rabbits. JPEN J Parenter Enteral Nutr 31: 199-204.
24. Yeh SL, Chang KY, Huang PC, Chen WJ, (1997) Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 13: 32-36.
25. Miloudi K, Comte B, Rouleau T, Montoudis A, Levy E, et al. (2012) The mode of administration of total parenteral nutrition and nature of lipid content influence the generation of peroxides and aldehydes. Clin Nutr 31: 526-534 doi:10.1016/j.clnu.2011.12.012.
26. Jump DB, (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13: 155-164.
27. Dentin R, Benhamed F, Pégorier J-P, Foufelle F, Viollet B, et al. (2005) Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115: 2843-2854 doi:10.1172/JCI25256.
28. Yahagi N, Shimano H, Hasty AH, Amemiya-Kudo M, Okazaki H, et al. (1999) A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem 274: 35840-35844.
29. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, et al. (2003) Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38: 1529-1539 doi:10.1016/j.hep.2003.09.028.
30. Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K, (2009) Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice. Prostaglandins Leukot Essent Fatty Acids 80: 229-238 doi:10.1016/j.plefa.2009.02.004.
31. Hall RI, Grant JP, Ross LH, Coleman RA, Bozovic MG, et al. (1984) Pathogenesis of hepatic steatosis in the parenterally fed rat. J Clin Invest 74: 1658-1668 doi:10.1172/JCI111582.
32. Wong S, Reardon M, Nestel P, (1985) Reduced triglyceride formation from long-chain polyenoic fatty acids in rat hepatocytes. Metab Clin Exp 34: 900-905.
33. Iritani N, Fukuda E, Kitamura Y, (1980) Effect of oxidized oil on lipogenic enzymes. Lipids 15: 371-374.